论文部分内容阅读
作者将有预后不良指标的早期类风湿性关节炎 (ＲＡ)患者随机分为 3组 ,分别用柳氮磺吡啶 (ＳＡＳＰ) ,甲氨蝶呤 (ＭＴＸ)及ＳＡＳＰ加ＭＴＸ治疗 ,对比 3组的疗效及耐受性。病人和方法 患者入选条件 :①符合美国风湿病学院 (ＡＣＲ)制定的ＲＡ分类标准 ;②疾病活动性评分 (Ｄ
The authors randomized patients with early stage rheumatoid arthritis (RA) with poor prognosis to three groups, treated with SASP, MTX and SASP plus MTX respectively. Efficacy and tolerance. Patients and methods Patient selection criteria: ① meet RA criteria set by the American College of Rheumatology (ACR); ② disease activity score (D